how to start my own crypto coin Overview

South Korea's KOSPI index rose 1% to 2,442.31.The decline of treasury bond futures expanded, with the 30-year main contract falling by 0.50%, the 30-year main contract falling by 0.50%, the 10-year main contract falling by 0.18%, the 5-year main contract falling by 0.12% and the 2-year main contract falling by 0.05%.Hong Kong stock Fosun's tourism culture opened 83.25% higher. In the news, the company plans to privatize at a premium of about 95.00%.

Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.50 Hong Kong stocks were repurchased by the company yesterday, with Tencent Holdings, Guangzhou Automobile Group and AIA having the largest amount of repurchase. On December 10th, a total of 50 Hong Kong stocks were repurchased by the company, and the amount of repurchase of 8 stocks exceeded HK$ 10 million. Among them, Tencent Holdings, Guangzhou Automobile Group and AIA have the largest repurchase amounts, with the repurchase amounts of HK$ 703 million, HK$ 64,988,500 and HK$ 62,310,000 respectively.In early trading, most of the main contracts of domestic futures fell. Palm oil fell more than 2%, alumina, Shanghai nickel, coking coal, glass, iron ore, soda ash and lithium carbonate fell more than 1%, and No.20 glue, methanol and stainless steel (SS) fell nearly 1%. In terms of increase, the Shanghai-Tianjin and Container Lines Europe rose by over 1%, while vegetable oil and fuel oil rose by nearly 1%.

How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.The AI application steering wheel went down at the beginning, Huayang Lianzhong fell, the AI application steering wheel went down at the beginning, Huayang Lianzhong fell, Fengyuzhu, Fushi Holdings, Wanxing Technology, Jincai Internet, Tianyu Digital Branch and so on followed.The speaker of South Korea's National Assembly called for an investigation into martial law.